Kawabata-Iwakawa R - Search Results

1

EphA4 signaling is involved in the phenotype of well-differentiated oral squamous cell arcinoma with decreased tumor immunity.

Kina S, Kawabata-Iwakawa R, Miyamoto S, Kato T, Kina-Tanada M, Arasaki A. Kina S, et al. Eur J Pharmacol. 2023 Apr 15;945:175611. doi: 10.1016/j.ejphar.2023.175611. Epub 2023 Feb 18. Eur J Pharmacol. 2023. PMID: 36804938 Free article.

2

A molecular signature of well-differentiated oral squamous cell carcinoma reveals a resistance mechanism to metronomic chemotherapy and novel therapeutic candidates.

Kina S, Kawabata-Iwakawa R, Miyamoto S, Arasaki A, Sunakawa H, Kinjo T. Kina S, et al. J Drug Target. 2021 Dec;29(10):1118-1127. doi: 10.1080/1061186X.2021.1929256. Epub 2021 May 27. J Drug Target. 2021. PMID: 33979258

3

Molecular phenotypes of circulating tumor cells and efficacy of nivolumab treatment in patients with head and neck squamous cell carcinoma.

Tada H, Takahashi H, Kawabata-Iwakawa R, Nagata Y, Uchida M, Shino M, Ida S, Mito I, Matsuyama T, Chikamatsu K. Tada H, et al. Sci Rep. 2020 Dec 9;10(1):21573. doi: 10.1038/s41598-020-78741-0. Sci Rep. 2020. PMID: 33299117 Free PMC article.

4

AKT3 Is a Novel Regulator of Cancer-Associated Fibroblasts in Head and Neck Squamous Cell Carcinoma.

Takahashi H, Rokudai S, Kawabata-Iwakawa R, Sakakura K, Oyama T, Nishiyama M, Chikamatsu K. Takahashi H, et al. Cancers (Basel). 2021 Mar 11;13(6):1233. doi: 10.3390/cancers13061233. Cancers (Basel). 2021. PMID: 33799788 Free PMC article.

5

AKT3 is a key regulator of head and neck squamous cell carcinoma.

Takahashi H, Rokudai S, Kawabata-Iwakawa R, Sakakura K, Oyama T, Nishiyama M, Chikamatsu K. Takahashi H, et al. Cancer Sci. 2021 Jun;112(6):2325-2334. doi: 10.1111/cas.14911. Epub 2021 May 1. Cancer Sci. 2021. PMID: 33811778 Free PMC article.

6

Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma.

Mito I, Takahashi H, Kawabata-Iwakawa R, Ida S, Tada H, Chikamatsu K. Mito I, et al. Sci Rep. 2021 Aug 9;11(1):16134. doi: 10.1038/s41598-021-95718-9. Sci Rep. 2021. PMID: 34373557 Free PMC article.

7

Upregulated glycolysis correlates with tumor progression and immune evasion in head and neck squamous cell carcinoma.

Takahashi H, Kawabata-Iwakawa R, Ida S, Mito I, Tada H, Chikamatsu K. Takahashi H, et al. Sci Rep. 2021 Sep 7;11(1):17789. doi: 10.1038/s41598-021-97292-6. Sci Rep. 2021. PMID: 34493792 Free PMC article.

8

Tissue-resident memory T cells correlate with the inflammatory tumor microenvironment and improved prognosis in head and neck squamous cell carcinoma.

Ida S, Takahashi H, Kawabata-Iwakawa R, Mito I, Tada H, Chikamatsu K. Ida S, et al. Oral Oncol. 2021 Nov;122:105508. doi: 10.1016/j.oraloncology.2021.105508. Epub 2021 Sep 8. Oral Oncol. 2021. PMID: 34507204

9

Circulating naïve and effector memory T cells correlate with prognosis in head and neck squamous cell carcinoma.

Takahashi H, Sakakura K, Ida S, Kawabata-Iwakawa R, Matsuyama T, Tada H, Mito I, Chikamatsu K. Takahashi H, et al. Cancer Sci. 2022 Jan;113(1):53-64. doi: 10.1111/cas.15195. Epub 2021 Nov 16. Cancer Sci. 2022. PMID: 34751489 Free PMC article.

10

Tumor-derived exosomes elicit cancer-associated fibroblasts shaping inflammatory tumor microenvironment in head and neck squamous cell carcinoma.

Mito I, Takahashi H, Kawabata-Iwakawa R, Horikawa M, Ida S, Tada H, Matsuyama T, Misawa K, Takeda S, Chikamatsu K. Mito I, et al. Oral Oncol. 2023 Jan;136:106270. doi: 10.1016/j.oraloncology.2022.106270. Epub 2022 Nov 30. Oral Oncol. 2023. PMID: 36462328

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters